This inventor holds 1 USPTO granted patent. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2007.
Company Filing History:
Years Active: 2007
Title: Innovations of Luping Chen in Biochemistry
Introduction
Luping Chen is a notable inventor based in Newtown, PA (US). He has made significant contributions to the field of biochemistry, particularly in the area of nucleotide and amino acid sequences. His work has implications for therapeutic applications, showcasing the potential of his inventions in medical science.
Latest Patents
Luping Chen holds a patent for "Acetyl CoA carboxylase 2 sequences and methods." This invention relates to novel human acetyl CoA carboxylase 2 (ACC2) and rat ACC2 sequences. The sequences can be expressed in a recombinant format, and methods for isolating the ACC2 sequence are also provided. These sequences can be utilized in therapeutic applications to diagnose or treat conditions associated with ACC2. Furthermore, the invention includes the identification of modulators of ACC activity using the recombinant human ACC2 enzyme as a screening target. He has 1 patent to his name.
Career Highlights
Luping Chen is associated with Bristol-Myers Squibb Company, a leading biopharmaceutical company. His work at this organization has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry. His expertise in biochemistry has been instrumental in advancing the understanding of ACC2 and its applications.
Collaborations
Luping Chen has collaborated with notable colleagues, including Dong Cheng and John N Feder. These collaborations have fostered a productive environment for innovation and research, enhancing the impact of their collective work in the field.
Conclusion
Luping Chen's contributions to biochemistry, particularly through his patent on acetyl CoA carboxylase 2 sequences, highlight his role as an innovator in the pharmaceutical industry. His work continues to pave the way for advancements in therapeutic applications.